BlueAllele® Corporation Continues to Advance Therapeutic Approaches Using Novel Gene Correction Technologies and Secures Third Patent from the USPTO View more
BlueAllele Corporation Secures Second Patent from USPTO Strengthening the Company’s Position in Targeted Insertion and Gene Correction Technologies View more
